|
1
|
Kásler M, Ottó S and Kenessey I: The
current situation of cancer morbidity and mortality in the light of
the national cancer registry. Orv Hetil. 158:84–89. 2017.(In
Hungarian). View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sun X, Liu W, Wu S, Han H, Lin Y and Dai
X: The morbidity and mortality trend and prediction of lung cancer
in residents of Nangang District of Harbin in China during the past
10 years. Zhongguo Fei Ai Za Zhi. 8:514–517. 2005.(In Chinese).
PubMed/NCBI
|
|
3
|
Fukunaga S, Nagami Y, Shiba M, Ominami M,
Tanigawa T, Yamagami H, Tanaka H, Muguruma K, Watanabe T, Tominaga
K, et al: Long-term prognosis of expanded-indication
differentiated-type early gastric cancer treated with endoscopic
submucosal dissection or surgery using propensity score analysis.
Gastrointest Endosc. 85:143–152. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dittmar Y, Schüle S, Koch A, Rauchfuss F,
Scheuerlein H and Settmacher U: Predictive factors for survival and
recurrence rate in patients with node-negative gastric cancer-a
European single-centre experience. Langenbecks Arch Surg.
400:27–35. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Greenhill C: Gastric cancer. Metformin
improves survival and recurrence rate in patients with diabetes and
gastric cancer. Nat Rev Gastroenterol Hepatol. 12:1242015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang Q and Ye M: Chemical analysis of the
Chinese herbal medicine Gan-Cao (licorice). J Chromatogr A.
1216:1954–1969. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang R, Yuan BC, Ma YS, Zhou S and Liu Y:
The anti-inflammatory activity of licorice, a widely used Chinese
herb. Pharm Biol. 55:5–18. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen X, Liu Z, Meng R, Shi C and Guo N:
Antioxidative and anticancer properties of Licochalcone A from
licorice. J Ethnopharmacol. 198:331–337. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang LP and Li JG: Glabridin reduces
lipopolysaccharide-induced lung injury in rats by inhibiting p38
mitogen activated protein kinase/extracellular regulated protein
kinases signaling pathway. Zhonghua Yi Xue Za Zhi. 96:3893–3897.
2016.(In Chinese). PubMed/NCBI
|
|
10
|
Liu C, Sui H, Zhao Q, Zhang X and Wang W:
Enhanced skin permeation of Glabridin using eutectic mixture-based
nanoemulsion. Drug Deliv Transl Res. 7:325–332. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ito C, Oi N, Hashimoto T, Nakabayashi H,
Aoki F, Tominaga Y, Yokota S, Hosoe K and Kanazawa K: Absorption of
dietary licorice isoflavan glabridin to blood circulation in rats.
J Nutr Sci Vitaminol (Tokyo). 53:358–365. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cao J, Chen X, Liang J, Yu XQ, Xu AL, Chan
E, Wei D, Huang M, Wen JY, Yu XY, et al: Role of P-glycoprotein in
the intestinal absorption of glabridin, an active flavonoid from
the root of Glycyrrhiza glabra. Drug Metab Dispos. 35:539–553.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ye X, Jiang F, Li Y, Mu J, Si L, Wang X,
Ning S and Li Z: Glabridin attenuates the migratory and invasive
capacity of breast cancer cells by activating microRNA-200c. Cancer
Sci. 105:875–882. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tsai YM, Yang CJ, Hsu YL, Wu LY, Tsai YC,
Hung JY, Lien CT, Huang MS and Kuo PL: Glabridin inhibits
migration, invasion, and angiogenesis of human non-small cell lung
cancer A549 cells by inhibiting the FAK/rho signaling pathway.
Integr Cancer Ther. 10:341–349. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tamir S, Eizenberg M, Somjen D, Stern N,
Shelach R, Kaye A and Vaya J: Estrogenic and antiproliferative
properties of glabridin from licorice in human breast cancer cells.
Cancer Res. 60:5704–5709. 2000.PubMed/NCBI
|
|
16
|
Jiang F, Mu J, Wang X, Ye X, Si L, Ning S,
Li Z and Li Y: The repressive effect of miR-148a on TGF beta-SMADs
signal pathway is involved in the glabridin-induced inhibition of
the cancer stem cells-like properties in hepatocellular carcinoma
cells. PLoS One. 9:e966982014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jiang F, Li Y, Mu J, Hu C, Zhou M, Wang X,
Si L, Ning S and Li Z: Glabridin inhibits cancer stem cell-like
properties of human breast cancer cells: An epigenetic regulation
of miR-148a/SMAd2 signaling. Mol Carcinog. 55:929–940. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hsieh MJ, Lin CW, Yang SF, Chen MK and
Chiou HL: Glabridin inhibits migration and invasion by
transcriptional inhibition of matrix metalloproteinase 9 through
modulation of NF-κB and AP-1 activity in human liver cancer cells.
Br J Pharmacol. 171:3037–3050. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Retraction statement: ‘Glabridin
attenuates the migratory and invasive capacity of breast cancer
cells by activating microRNA-200c’. by. Xianqing Ye, Fei Jiang,
Yuan Li, Juan Mu, Lu Si, Xingxing Wang, Shilong Ning, Zhong L..
Cancer Sci. 106:1252015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nabekura T, Yamaki T, Ueno K and Kitagawa
S: Inhibition of P-glycoprotein and multidrug resistance protein 1
by dietary phytochemicals. Cancer Chemother Pharmacol. 62:867–873.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Khazraei-Moradian S, Ganjalikhani-Hakemi
M, Andalib A, Yazdani R, Arasteh J and Kardar GA: The effect of
licorice protein fractions on proliferation and apoptosis of
gastrointestinal cancer cell lines. Nutr Cancer. 69:330–339. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhou X, Wang W, Li P, Zheng Z, Tu Y, Zhang
Y and You T: Curcumin enhances the effects of 5-fluorouracil and
oxaliplatin in inducing gastric cancer cell apoptosis both in vitro
and in vivo. Oncol Res. 23:29–34. 2016. View Article : Google Scholar
|
|
23
|
Alimperti S and Andreadis ST: CDH2 and
CDH11 act as regulators of stem cell fate decisions. Stem Cell Res.
14:270–282. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Saika K and Sobue T: Cancer statistics in
the world. Gan To Kagaku Ryoho. 40:2475–2480. 2013.(In Japanese).
PubMed/NCBI
|
|
25
|
Zeng H, Zheng R, Zhang S, Zuo T, Xia C,
Zou X and Chen W: Esophageal cancer statistics in China, 2011:
Estimates based on 177 cancer registries. Thorac Cancer. 7:232–237.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kinoshita T, Kajiyama K, Hiraga Y,
Takahashi K, Tamura Y and Mizutani K: Isoflavan derivatives from
Glycyrrhiza glabra (licorice). Heterocycles. 43:581–588. 1996.
View Article : Google Scholar
|
|
28
|
Vaya J, Belinky PA and Aviram M:
Antioxidant constituents from licorice roots: Isolation, structure
elucidation and antioxidative capacity toward LDL oxidation. Free
Radic Biol Med. 23:302–313. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fulmer CG, Hoda RS, Pirog EC, Park KJ and
Holcomb K: Cytomorphology of gastric-type cervical adenocarcinoma
on a ThinPrep Pap test: Report of a p16-positive tumor case. Diagn
Cytopathol. 44:710–713. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kosemehmetoglu K, Ardic F, Karslioglu Y,
Kandemir O and Ozcan A: p16 expression predicts neoadjuvant tumor
necrosis in osteosarcomas: Reappraisal with a larger series using
whole sections. Hum Pathol. 50:170–175. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Benassi MS, Molendini L, Gamberi G,
Ragazzini P, Sollazzo MR, Merli M, Asp J, Magagnoli G, Balladelli
A, Bertoni F and Picci P: Alteration of pRb/p16/cdk4 regulation in
human osteosarcoma. Int J Cancer. 84:489–493. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dobashi Y, Goto A, Fukayama M, Abe A and
Ooi A: Overexpression of cdk4/cyclin D1, a possible mediator of
apoptosis and an indicator of prognosis in human primary lung
carcinoma. Int J Cancer. 110:532–541. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Maelandsmo GM, Flørenes VA, Hovig E,
Oyjord T, Engebraaten O, Holm R, Børresen AL and Fodstad O:
Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the
tumorigenesis of sporadic malignant melanomas. Br J Cancer.
73:909–916. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Rossi KA, Markwalder JA, Seitz SP, Chang
CH, Cox S, Boisclair MD, Brizuela L, Brenner SL and Stouten PF:
Understanding and modulating cyclin-dependent kinase inhibitor
specificity: Molecular modeling and biochemical evaluation of
pyrazolopyrimidinones as CDK2/cyclin A and CDK4/cyclin D1
inhibitors. J Comput Aided Mol Des. 19:111–122. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lee SK, Park KK, Park JH, Lim SS and Chung
WY: The inhibitory effect of roasted licorice extract on human
metastatic breast cancer cell-induced bone destruction. Phytother
Res. 27:1776–1783. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jo EH, Hong HD, Ahn NC, Jung JW, Yang SR,
Park JS, Kim SH, Lee YS and Kang KS: Modulations of the Bcl-2/Bax
family were involved in the chemopreventive effects of licorice
root (Glycyrrhiza uralensis Fisch) in MCF-7 human breast cancer
cell. J Agric Food Chem. 52:1715–1719. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jo EH, Kim SH, Ra JC, Kim SR, Cho SD, Jung
JW, Yang SR, Park JS, Hwang JW, Aruoma OI, et al: Chemopreventive
properties of the ethanol extract of chinese licorice (Glycyrrhiza
uralensis) root: Induction of apoptosis and G1 cell cycle arrest in
MCF-7 human breast cancer cells. Cancer Lett. 230:239–247. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Brahmbhatt H, Oppermann S, Osterlund EJ,
Leber B and Andrews DW: Molecular pathways: Leveraging the BCL-2
interactome to kill cancer cells-mitochondrial outer membrane
permeabilization and beyond. Clin Cancer Res. 21:2671–2676. 2015.
View Article : Google Scholar : PubMed/NCBI
|
